2012
DOI: 10.1002/ajmg.a.35264
|View full text |Cite
|
Sign up to set email alerts
|

Long‐term survival in infantile malignant autosomal recessive osteopetrosis secondary to homozygous p.Arg526Gln mutation in CLCN7

Abstract: Infantile malignant autosomal recessive osteopetrosis (ARO; OMIM 259700) has been reported to be associated with mutations in TCIRG1, CLCN7, or OSTM1. ARO caused by homozygous (or compound heterozygous) mutations in CLCN7, as described here, is usually diagnosed at birth or early in infancy due to generalized osteosclerosis and severe hematologic deficits. The maximal life expectancy of patients with ARO in the absence of bone marrow transplantation is thought to be 10 years. We report on a 25-year-old Thai ma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 26 publications
0
6
0
Order By: Relevance
“…(38) Interestingly, also osteoclasts from Clcn7-deficient mice and a patient with CLCN7-related autosomal recessive osteopetrosis have a larger diameter for an unknown reason. (30,39,40) Lrrk1 −/− mice were resistant to ovariectomy (OVX)-induced bone loss at the spine, femur, and tibia and showed elevated total bone mass density (BMD) at all three skeletal sites at time of OVX. (7) LRRK1 has hence been contemplated as a potential target for osteoanabolic therapy.…”
Section: Discussionmentioning
confidence: 99%
“…(38) Interestingly, also osteoclasts from Clcn7-deficient mice and a patient with CLCN7-related autosomal recessive osteopetrosis have a larger diameter for an unknown reason. (30,39,40) Lrrk1 −/− mice were resistant to ovariectomy (OVX)-induced bone loss at the spine, femur, and tibia and showed elevated total bone mass density (BMD) at all three skeletal sites at time of OVX. (7) LRRK1 has hence been contemplated as a potential target for osteoanabolic therapy.…”
Section: Discussionmentioning
confidence: 99%
“…This does not exclude the possibility that other hypomorphic OSTM1 mutations could lead to a mild osteopetrotic phenotype in humans. The recent identification of a similar mutation in CLC7 (Kantaputra et al 2012) confirms the idea that many more subtle mutations may be identified in the human population. Therapy for osteopetrosis is presently unsatisfactory and much work needs to done to unravel the gene defects and to identify new treatments to improve symptoms.…”
Section: Discussionmentioning
confidence: 69%
“…Various forms of recessive osteopetrosis have been reported, some of which are associated with the most severe phenotypes (including those caused by mutations in the TCIRG1 , CLC7 , and OSTM1 genes), whereas mutations in other genes ( CAII and PLEKHM1 ) give a milder osteopetrotic phenotype. Recently, long-term survival in infantile malignant autosomal recessive osteopetrosis secondary to homozygous p.Arg526Gln mutation in CLCN7 was described (Kantaputra et al 2012). Interestingly, the phenotype of omi mice greatly overlaps the description of a case study of recessive mild osteopetrosis (Kahler et al 1984).…”
Section: Discussionmentioning
confidence: 99%
“…Hsa-miR-23a is among several miRNAs currently miRNA-target pairs associated with osteopetrosis M Ou et al considered as suppressors of osteoblast differentiation, upregulated hsa-miR-23a in PBMCs may be involved in the abnormal osteoclasts found in osteopetrosis-specific PBMC-induced osteoclasts. 20 Hsa-miR-29b-3p in the miR-29abcd family was among the most significantly downregulated miRNAs in osteopetrosis library. This is consistent with a putative role of downregulation of hsa-miR-29b-3p in decreased osteoclastogenesis in osteopetrosis-specific PBMCinduced osteoclasts.…”
Section: Discussionmentioning
confidence: 93%